Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000213010 | SCV000211678 | benign | not specified | 2014-01-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000160969 | SCV000213678 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000590217 | SCV000227128 | uncertain significance | not provided | 2015-04-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000195629 | SCV000253249 | benign | Peutz-Jeghers syndrome | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000195629 | SCV000410735 | uncertain significance | Peutz-Jeghers syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Counsyl | RCV000195629 | SCV000488905 | likely benign | Peutz-Jeghers syndrome | 2016-07-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000160969 | SCV000686637 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-18 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000590217 | SCV000696716 | benign | not provided | 2016-09-30 | criteria provided, single submitter | clinical testing | Variant summary: The STK11 c.357C>T (p.Asn119Asn) variant causes a synonymous change involving a non-conserved nucleotide with 5/5 splice prediction tools predicting no significant impact on normal splicing. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 10/120328 (1/12032), which is approximately 13 times the estimated maximal expected allele frequency for a pathogenic STK11 variant 1/158730 (0.0000063), suggesting this variant is likely a benign polymorphism. In addition, multiple clinical diagnostic laboratories have classified this variant as benign/likely benign. One internal sample carrying this variant also carries another likely pathogenic variant RAD51C c.93delG, further supporting the benign outcome. Taken together, this variant is classified as Benign. |
Ce |
RCV000590217 | SCV001248462 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | STK11: BP4, BP7 |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000213010 | SCV001469914 | benign | not specified | 2020-04-20 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000590217 | SCV001473727 | likely benign | not provided | 2019-11-24 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000195629 | SCV002057237 | likely benign | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000213010 | SCV002065598 | likely benign | not specified | 2020-12-18 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000160969 | SCV002531685 | benign | Hereditary cancer-predisposing syndrome | 2021-04-29 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV000195629 | SCV004017956 | benign | Peutz-Jeghers syndrome | 2023-04-13 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
All of Us Research Program, |
RCV000195629 | SCV004816347 | likely benign | Peutz-Jeghers syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000213010 | SCV005089907 | likely benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing |